Identifying essential long non-coding RNAs in cancer using CRISPRi-based dropout screens.

Oscar Bril1, Laura J Schwarzmueller1, Leandro F Moreno1

  • 1Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam 1105AZ, The Netherlands; Oncode Institute, Meibergdreef 9, Amsterdam 1105AZ, The Netherlands.

STAR Protocols
|September 29, 2023
PubMed
Summary

This study introduces a CRISPR interference (CRISPRi) dropout screen protocol to identify essential long non-coding RNAs (lncRNAs) in cancer. This method systematically uncovers lncRNAs critical for cancer progression.